Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients

Journal of Clinical Virology

Volumn 43, Issue 1, 2008, Pages 79-85

  Gustafson, I ^a   Lindblom, A ^a   Yun, Z ^b   Omar, H ^a,b   Engstrom, L ^b   Lewensohn Fuchs, I ^b   Ljungman, P ^a,b   Broliden, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenovirus; Immunosuppression; Quantitative PCR; Transplantation

Indexed keywords

ADENOVIRUS DNA; ALEMTUZUMAB; CYCLOSPORIN A; METHOTREXATE; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA;

ADENOVIRUS; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CYTOMEGALOVIRUS; ENGRAFTMENT; EPSTEIN BARR VIRUS; EVALUATION; FOLLOW UP; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VIREMIA; VIRUS LOAD;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; DNA, VIRAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIRAL LOAD;

EID: 49949107392     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.04.014     Document Type: Article

References (35)

1. Baldwin A., Kingman H., Darville M., Foot A.B.M., Grier D., Cornish J.M., et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant. 26 (2000) 1333-1338
2. Carrigan D.R. Adenovirus infections in immunocompromised patients. Am. J. Med. 102 (1997) 71-74
3. Chakrabarti S., Mautner V., Osman H., Collingham K.E., Fegan C.D., Klapper P.E., et al. Adenovirus infections following allogenic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression and immune recovery. Blood 100 (2002) 1619-1627
4. Childs R., Sanchez C., Engler H., Preuss J., Rosenfeld S., Dunbar C., et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant. 22 (1998) 889-893
5. Claas E.C.J., Schilham M.W., de Brouwer C.S., Hubacek P., Echavarria M., Lankester A.C., et al. Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J. Clin. Microbiol. 43 (2005) 1738-1744
6. Echavarria M., Forman M., van Tol M.J.D., Vossen J.M., Charache P., and Kroes A.C.M. Prediction of severe disseminated adenovirus infection by serum PCR. Lancet 358 (2001) 384-385
7. Emery V.C., Sabin C.A., Cope A.V., Gor D., Hassan-Walker A.F., and Griffiths P.D. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 335 (2000) 2032-2036
8. Flomenberg P., Babbitt J., Drobyski W.R., Ash R.C., Carrigan D.R., Sedmak G.V., et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Infect. Dis. 169 (1994) 775-781
9. Flomenberg P., Gutierrez E., Piaskowski V., and Casper J.T. Detection of adenovirus DNA in peripheral blood mononuclear cells by polymerase chain reaction assay. J. Med. Virol. 51 (1997) 182-188
10. Gavin P.J., and Katz B.Z. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110 (2002) e9
11. Garrigue I., Boucher S., Couzi L., Caumont A., Dromer C., Neau-Cransac M., et al. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J. Clin. Virol. 36 (2006) 72-75
12. Hale G.A., Heslop H.E., Krance R.A., Brenner M.A., Jayawardene D., Srivastava D.K., et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 23 (1999) 277-282
13. Heim A., Ebnet C., Harste G., and Pring-Åkerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 70 (2003) 228-239
14. Horvath J., Palkonyay L., and Weber J. Group C adenovirus DNA sequences in human lymphoid cells. J. Virol. 59 (1986) 189-192
15. Howard D.S., Phillips II G.L., Reece D.E., Munn R.K., Henslee-Downey J., Pittard M., et al. Adenovirus infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 29 (1999) 1494-1501
16. Johansson M.E., Andersson M.A., and Thörner P.A. Adenoviruses isolated in the Stockholm area during 1987-1992: restriction endonuclease analysis and molecular epidemiology. Arch. Virol. 137 (1994) 101-115
17. Kalpoe J.S., van der Heiden P.L.J., Barge R.M.Y., Houtzager S., Lankester A.C., van Tol M.J.D., et al. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur. J. Haematol. 78 (2007) 314-321
18. La Rosa A.M., Champlin R.E., Mirza N., Gajewski J., Giralt S., Rolston K.V., et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin. Infect. Dis. 32 (2001) 871-876
19. Lankester A.C., Heemskerk B., Claas E.C.J., Schilham M.W., Beersma M.F.C., Bredius R.G.M., et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin. Infect. Dis. 38 (2004) 1521-1525
20. Le Blanc K., Remberger M., Uzunel M., Mattsson J., Barkholt L., and Ringdén O. A comparison of nonmyeloablative and reduced-intensity conditioning for allogenic stem transplantation. Transplantation 78 (2004) 1014-1020
21. Leen A.M., and Rooney C.M. Adenovirus as an emerging pathogen in immunocompromised patients. Br. J. Haematol. 128 (2005) 135-144
22. Legrand F., Berrebi D., Houhou N., Freymuth F., Faye A., Duval M., et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant. 27 (2001) 621-626
23. Lion T., Baumgartinger R., Watzinger F., Matthes-Martin S., Suda M., Preuner S., et al. Molecular monitoring of adenovirus in peripheral blood after allogenic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102 (2003) 1114-1120
24. Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 583-588
25. Ljungman P., Perez-Bercoff L., Jonsson J., Avetisyan G., Sparrelid E., Aschan J., et al. Risk factors for the development of cytomegalovirus disease after allogenic stem cell transplantation. Haematol 91 (2006) 78-83
26. Niesters H.G.M., van Esser J., Fries E., Wolthers K.C., Cornelissen J., and Osterhaus A.D.M.E. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J. Clin. Microbiol. 38 (2000) 712-715
27. Reusser P., Einsele H., Lee J., Volin L., Rovira M., Engelhard D., et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood 99 (2002) 1159-1164
28. Runde V., Ross S., Trenschel R., Lagemann E., Basu O., Renzing-Köhler K., et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant. 28 (2001) 51-57
29. Schilham M.W., Claas E.C., van Zaane W., Heemskerk B., Vossen J.M., Lankester A.C., et al. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin. Infect. Dis. 35 (2002) 526-532
30. Takayama R., Hatakeyama N., Suzuki N., Yamamoto M., Hayashi T., Ikeda Y., et al. Quantification of adenovirus species B and C viremia by real-time PCR in adults and children undergoing stem cell transplantation. J. Med. Virol. 79 (2007) 278-284
31. van Tol M.J.D., Kroes A.C.M., Schinkel J., Dinkelaar W., Claas E.C.J., Jol-van der Zijde C.M., et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant. 36 (2005) 39-50
32. Walls T., Hawrami K., Ushiro-Lumb I., Shingadia, Saha D.V., and Shankar A.G. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary?. Clin. Infect. Dis. 40 (2005) 1244-1249
33. Wasserman R., August C.S., and Plotkin S.A. Viral infections in pediatric bone marrow transplant patients. Pediatr. Infect. Dis. 7 (1988) 109-115
34. Yun Z., Lewensohn-Fuchs I., Ljungman P., Ringholm L., Jonsson J., and Albert J. A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients. J. Virol. Methods 110 (2003) 73-79
35. Yusuf U., Hale G.A., Carr J., Gu Z., Benaim E., Woodard P., et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 81 (2006) 1398-1404